QB3's VC Fund Raises $7.5M to Fund Startups | GenomeWeb

NEW YORK (GenomeWeb News) – The new venture capital firm created by the California Institute for Quantitative Biosciences, or QB3, is in "due diligence" review phases of selecting its first of 15 startups set to receive portions of a recently raised $7.5 million seed money fund.

Mission Bay Capital LLC is "expecting to make two to four investments a year over the next three or four years," Douglas Crawford, QB3's director of industry alliances and associate executive director, told GenomeWeb Daily News on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.